Revenue
Unlock this feature
To access this exclusive feature and unlock the full potential of our platform, upgrade to our PRO plan.
BioPharmaceuticals: CVRM Revenue
+ 2.66 %
+ 30.03 %
Oncology Revenue
+ 2.48 %
+ 27.8 %
BioPharmaceuticals V&I Revenue
- 0.58 %
- 5.65 %
Other Medicines Revenue
- 0.52 %
- 5.11 %
Rare Disease Revenue
+ 0.31 %
+ 3.1 %
BioPharmaceuticals: R&I Revenue
- 2.31 %
- 20.87 %
Revenue by Geography
Unlock this feature
To access this exclusive feature and unlock the full potential of our platform, upgrade to our PRO plan.
UK Revenue
+ 1.98 %
+ 21.69 %
The Americas Revenue
- 0.49 %
- 4.76 %
Rest of Europe Revenue
- 1.42 %
- 13.3 %
Asia, Africa & Australasia Revenue
- 1.13 %
- 10.78 %
EBIT by Geography
Unlock this feature
To access this exclusive feature and unlock the full potential of our platform, upgrade to our PRO plan.
UK Operating Profit
- 0.71 %
- 6.92 %
Rest of Europe Operating Profit
- 1.29 %
- 12.16 %
The Americas Operating Profit
+ 0.94 %
+ 9.8 %
Asia, Africa & Australasia Operating Profit
- 2.17 %
- 19.66 %
Capital Expenditures by Geography
Unlock this feature
To access this exclusive feature and unlock the full potential of our platform, upgrade to our PRO plan.
UK Assets Acquired
- 0.89 %
- 8.52 %
Rest of Europe Assets Acquired
+ 2.25 %
+ 24.92 %
The Americas Assets Acquired
- 1.4 %
- 13.19 %
Asia, Africa & Australasia Assets Acquired
- 2.62 %
- 23.36 %
